The addition of granulocyte-colony stimulating factor shifts the dose limiting toxicity and markedly increases the maximum tolerated dose and activity of the kinesin spindle protein inhibitor SB-743921 in patients with relapsed or refractory lymphom (Q33420259)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The addition of granulocyte-colony stimulating factor shifts the dose limiting toxicity and markedly increases the maximum tolerated dose and activity of the kinesin spindle protein inhibitor SB-743921 in patients with relapsed or refractory lymphom |
scientific article |
Statements
1 reference
The addition of granulocyte-colony stimulating factor shifts the dose limiting toxicity and markedly increases the maximum tolerated dose and activity of the kinesin spindle protein inhibitor SB-743921 in patients with relapsed or refractory lymphom (English)
1 reference
John Hainsworth
1 reference
Owen A O'Connor
1 reference
John Gerecitano
1 reference
Henrik Van Deventer
1 reference
Kelly M Zullo
1 reference
Khalil Saikali
1 reference
Joseph Seroogy
1 reference
Andrew Wolff
1 reference
Rafael Escandón
1 reference
10 February 2015
1 reference
1 reference
56
1 reference
2585-2591
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference